These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 18253929)

  • 1. Viral danger signals control CD1d de novo synthesis and NKT cell activation.
    Raftery MJ; Winau F; Giese T; Kaufmann SH; Schaible UE; Schönrich G
    Eur J Immunol; 2008 Mar; 38(3):668-79. PubMed ID: 18253929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids.
    Paget C; Mallevaey T; Speak AO; Torres D; Fontaine J; Sheehan KC; Capron M; Ryffel B; Faveeuw C; Leite de Moraes M; Platt F; Trottein F
    Immunity; 2007 Oct; 27(4):597-609. PubMed ID: 17950005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells.
    Trobonjaca Z; Leithäuser F; Möller P; Schirmbeck R; Reimann J
    J Immunol; 2001 Aug; 167(3):1413-22. PubMed ID: 11466360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo.
    Ilyinskii PO; Wang R; Balk SP; Exley MA
    J Virol; 2006 Jul; 80(14):7146-58. PubMed ID: 16809320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bovine CD1 family contains group 1 CD1 proteins, but no functional CD1d.
    Van Rhijn I; Koets AP; Im JS; Piebes D; Reddington F; Besra GS; Porcelli SA; van Eden W; Rutten VP
    J Immunol; 2006 Apr; 176(8):4888-93. PubMed ID: 16585584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells.
    Marschner A; Rothenfusser S; Hornung V; Prell D; Krug A; Kerkmann M; Wellisch D; Poeck H; Greinacher A; Giese T; Endres S; Hartmann G
    Eur J Immunol; 2005 Aug; 35(8):2347-57. PubMed ID: 16025562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
    Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
    Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.
    Ikarashi Y; Mikami R; Bendelac A; Terme M; Chaput N; Terada M; Tursz T; Angevin E; Lemonnier FA; Wakasugi H; Zitvogel L
    J Exp Med; 2001 Oct; 194(8):1179-86. PubMed ID: 11602646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
    Metelitsa LS; Naidenko OV; Kant A; Wu HW; Loza MJ; Perussia B; Kronenberg M; Seeger RC
    J Immunol; 2001 Sep; 167(6):3114-22. PubMed ID: 11544296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments.
    Moll M; Andersson SK; Smed-Sörensen A; Sandberg JK
    Blood; 2010 Sep; 116(11):1876-84. PubMed ID: 20530791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD1 antigen presentation and infectious disease.
    Dascher CC; Brenner MB
    Contrib Microbiol; 2003; 10():164-82. PubMed ID: 12530326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I IFN-producing CD4 Valpha14i NKT cells facilitate priming of IL-10-producing CD8 T cells by hepatocytes.
    Wahl C; Bochtler P; Schirmbeck R; Reimann J
    J Immunol; 2007 Feb; 178(4):2083-93. PubMed ID: 17277112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
    Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
    Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKT cells: T lymphocytes with innate effector functions.
    Van Kaer L
    Curr Opin Immunol; 2007 Jun; 19(3):354-64. PubMed ID: 17428648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid regulates CD1d gene expression at the transcriptional level in human and rodent monocytic cells.
    Chen Q; Ross AC
    Exp Biol Med (Maywood); 2007 Apr; 232(4):488-94. PubMed ID: 17392484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Valpha24+Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients.
    van der Vliet HJ; Molling JW; von Blomberg BM; Kölgen W; Stam AG; de Gruijl TD; Mulder CJ; Janssen HL; Nishi N; van den Eertwegh AJ; Scheper RJ; van Nieuwkerk CJ
    Clin Immunol; 2005 Feb; 114(2):183-9. PubMed ID: 15639652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver.
    Kenna T; O'Brien M; Hogan AE; Exley MA; Porcelli SA; Hegarty JE; O'Farrelly C; Doherty DG
    Cancer Immunol Immunother; 2007 Apr; 56(4):563-72. PubMed ID: 16924493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human NKT cells express granulysin and exhibit antimycobacterial activity.
    Gansert JL; Kiessler V; Engele M; Wittke F; Röllinghoff M; Krensky AM; Porcelli SA; Modlin RL; Stenger S
    J Immunol; 2003 Mar; 170(6):3154-61. PubMed ID: 12626573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid Antigen Presentation by CD1b and CD1d in Lysosomal Storage Disease Patients.
    Pereira CS; Pérez-Cabezas B; Ribeiro H; Maia ML; Cardoso MT; Dias AF; Azevedo O; Ferreira MF; Garcia P; Rodrigues E; Castro-Chaves P; Martins E; Aguiar P; Pineda M; Amraoui Y; Fecarotta S; Leão-Teles E; Deng S; Savage PB; Macedo MF
    Front Immunol; 2019; 10():1264. PubMed ID: 31214199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR.
    Grubor-Bauk B; Simmons A; Mayrhofer G; Speck PG
    J Immunol; 2003 Feb; 170(3):1430-4. PubMed ID: 12538704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.